A 2024 cohort study by Miller-Matero and colleagues with 14,053 participants found that nearly half of those consuming alcohol at baseline reduced their alcohol intake after starting anti-obesity medications (primarily second-generation GLP-1s)
Your resiliency should balance it off
The treatment regimen included a preventive dose 60 15 minutes prior to MCAO, followed by daily doses for 7 days after reperfusion
Overview of Compounded Semaglutide in 2025 As 2025 progresses, the end of the national semaglutide shortage has significantly reduced the need for compounded alternatives
Black people with multiple sclerosis (MS) die from the disease at a younger age than white folks, a new study reports
Along with preclinical data indicating that long-acting GIPR agonists act in the brain to decrease body weight and food intake via GIPR signalling in inhibitory -aminobutyric acid-producing (GABAergic) neurons 5,6,7 , and by mitigating the emetic effects of GLP-1R agonism 8,9 , GIPRGLP-1R co-agonism has been established as a highly effective strategy for the management of obesity, type 2 diabetes and MASH
